Nicolas Pauillac
Stock Analyst at Kepler Capital
(4.73)
# 730
Out of 5,119 analysts
368
Total ratings
53.1%
Success rate
17%
Average return
Main Sectors:
Stocks Rated by Nicolas Pauillac
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EPA: MEDCL MedinCell S.A. | Downgraded: Hold | €36.60 → €31.00 | €28.44 | +9.00% | 34 | Oct 14, 2026 | |
| LON: GSK GSK plc | Upgraded: Buy | 1,500p → 2,516p | 1,890p | +33.12% | 2 | May 26, 2026 | |
| SWX: CMHC Cosmo N.V. | Reiterated: Buy | CHF 130.00 | CHF 56.80 | +128.87% | 35 | May 11, 2026 | |
| SWX: SDZ Sandoz Group AG | Reiterated: Buy | CHF 80.00 | CHF 83.78 | -4.51% | 29 | May 11, 2026 | |
| EPA: CVX Carvolix SA | Reiterated: Buy | €5.00 | €4.90 | +2.04% | 30 | May 4, 2026 | |
| EPA: OSE OSE Immunotherapeutics SA | Reiterated: Buy | €8.20 | €1.71 | +380.66% | 40 | Apr 30, 2026 | |
| SWX: IDIA Idorsia Ltd | Reiterated: Buy | CHF 4.50 | CHF 4.06 | +10.89% | 1 | Apr 28, 2026 | |
| SWX: BION BB Biotech AG | Reiterated: Buy | CHF 66.00 → CHF 73.00 | CHF 51.60 | +41.47% | 15 | Apr 24, 2026 | |
| EPA: SAN Sanofi | Reiterated: Hold | €85.00 | €83.74 | +1.50% | 16 | Apr 23, 2026 | |
| ETR: FYB Formycon AG | Reiterated: Buy | €33.00 | €14.10 | +134.04% | 51 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €20.30 | €13.80 | +47.10% | 34 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €5.00 | €2.62 | +90.84% | 8 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €15.00 | €6.45 | n/a | 1 | Sep 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €390.00 | €359.50 | n/a | 19 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | €0.80 → €0.64 | €0.04 | n/a | 21 | May 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $88 → $46 | $33.45 | n/a | 2 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €79.00 → €41.00 | €29.62 | n/a | 5 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $384 → $422 | $927.21 | n/a | 5 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | CHF 57.00 | CHF 71.00 | n/a | 10 | Nov 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €16.00 | €1.09 | n/a | 1 | Sep 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | €7.50 → €9.00 | €2.50 | n/a | 2 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €0.60 → €0.40 | €0.47 | n/a | 4 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €2.70 | €0.29 | n/a | 1 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €12.00 | €2.75 | n/a | 1 | Dec 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €16.00 | €77.15 | n/a | 1 | Dec 21, 2022 |
MedinCell S.A.
Oct 14, 2026
Downgraded: Hold
Price Target: €36.60 → €31.00
Current: €28.44
Upside: +9.00%
GSK plc
May 26, 2026
Upgraded: Buy
Price Target: 1,500p → 2,516p
Current: 1,890p
Upside: +33.12%
Cosmo N.V.
May 11, 2026
Reiterated: Buy
Price Target: CHF 130.00
Current: CHF 56.80
Upside: +128.87%
Sandoz Group AG
May 11, 2026
Reiterated: Buy
Price Target: CHF 80.00
Current: CHF 83.78
Upside: -4.51%
Carvolix SA
May 4, 2026
Reiterated: Buy
Price Target: €5.00
Current: €4.90
Upside: +2.04%
OSE Immunotherapeutics SA
Apr 30, 2026
Reiterated: Buy
Price Target: €8.20
Current: €1.71
Upside: +380.66%
Idorsia Ltd
Apr 28, 2026
Reiterated: Buy
Price Target: CHF 4.50
Current: CHF 4.06
Upside: +10.89%
BB Biotech AG
Apr 24, 2026
Reiterated: Buy
Price Target: CHF 66.00 → CHF 73.00
Current: CHF 51.60
Upside: +41.47%
Sanofi
Apr 23, 2026
Reiterated: Hold
Price Target: €85.00
Current: €83.74
Upside: +1.50%
Formycon AG
Apr 22, 2026
Reiterated: Buy
Price Target: €33.00
Current: €14.10
Upside: +134.04%
Apr 1, 2026
Reiterated: Buy
Price Target: €20.30
Current: €13.80
Upside: +47.10%
Feb 25, 2026
Reiterated: Buy
Price Target: €5.00
Current: €2.62
Upside: +90.84%
Sep 25, 2025
Reiterated: Hold
Price Target: €15.00
Current: €6.45
Upside: n/a
Jul 17, 2025
Reiterated: Hold
Price Target: €390.00
Current: €359.50
Upside: n/a
May 6, 2024
Reiterated: Sell
Price Target: €0.80 → €0.64
Current: €0.04
Upside: n/a
May 3, 2024
Reiterated: Hold
Price Target: $88 → $46
Current: $33.45
Upside: n/a
May 3, 2024
Reiterated: Hold
Price Target: €79.00 → €41.00
Current: €29.62
Upside: n/a
Feb 20, 2024
Reiterated: Hold
Price Target: $384 → $422
Current: $927.21
Upside: n/a
Nov 20, 2023
Reiterated: Buy
Price Target: CHF 57.00
Current: CHF 71.00
Upside: n/a
Sep 7, 2023
Reiterated: Buy
Price Target: €16.00
Current: €1.09
Upside: n/a
Aug 28, 2023
Upgraded: Buy
Price Target: €7.50 → €9.00
Current: €2.50
Upside: n/a
May 3, 2023
Reiterated: Buy
Price Target: €0.60 → €0.40
Current: €0.47
Upside: n/a
Apr 28, 2023
Reiterated: Buy
Price Target: €2.70
Current: €0.29
Upside: n/a
Dec 29, 2022
Reiterated: Buy
Price Target: €12.00
Current: €2.75
Upside: n/a
Dec 21, 2022
Reiterated: Buy
Price Target: €16.00
Current: €77.15
Upside: n/a